AAAAAA

   
Results: 1-9 |
Results: 9
Effectiveness of radiolabelled antibodies for radio-immunotherapy in a colorectal xenograft model: a comparative study using the linear-quadratic formulation
Authors: Flynn, AA Pedley, RB Green, AJ Boxer, GM Boden, R Dearling, J Bhatia, J Begent, RHJ
Citation: Aa. Flynn et al., Effectiveness of radiolabelled antibodies for radio-immunotherapy in a colorectal xenograft model: a comparative study using the linear-quadratic formulation, INT J RAD B, 77(4), 2001, pp. 507-517
Relationship between tumour morphology, antigen and antibody distribution measured by fusion of digital phosphor and photographic images
Authors: Flynn, AA Boxer, GM Begent, RHJ Pedley, RB
Citation: Aa. Flynn et al., Relationship between tumour morphology, antigen and antibody distribution measured by fusion of digital phosphor and photographic images, CANCER IMMU, 50(2), 2001, pp. 77-81
A mouse model for calculating the absorbed beta-particle dose from I-131- and Y-90-labeled immunoconjugates, including a method for dealing with heterogeneity in kidney and tumor
Authors: Flynn, AA Green, AJ Pedley, RB Boxer, GM Boden, R Begent, RHJ
Citation: Aa. Flynn et al., A mouse model for calculating the absorbed beta-particle dose from I-131- and Y-90-labeled immunoconjugates, including a method for dealing with heterogeneity in kidney and tumor, RADIAT RES, 156(1), 2001, pp. 28-35
A strategy for antitumor vascular therapy by targeting the vascular endothelial growth factor : receptor complex
Authors: Cooke, SP Boxer, GM Lawrence, L Pedley, RB Spencer, DIR Begent, RHJ Chester, KA
Citation: Sp. Cooke et al., A strategy for antitumor vascular therapy by targeting the vascular endothelial growth factor : receptor complex, CANCER RES, 61(9), 2001, pp. 3653-3659
Eradication of colorectal xenografts by combined radioimmunotherapy and combretastatin A-4 3-O-phosphate
Authors: Pedley, RB Hill, SA Boxer, GM Flynn, AA Boden, R Watson, R Dearling, J Chaplin, DJ Begent, RHJ
Citation: Rb. Pedley et al., Eradication of colorectal xenografts by combined radioimmunotherapy and combretastatin A-4 3-O-phosphate, CANCER RES, 61(12), 2001, pp. 4716-4722
Radioimmunoguided surgery in colorectal cancer using a genetically engineered anti-CEA single-chain Fv antibody
Authors: Mayer, A Tsiompanou, E O'Malley, D Boxer, GM Bhatia, J Flynn, AA Chester, KA Davidson, BR Lewis, AAM Winslet, MC Dhillon, AP Hilson, AJW Begent, RHJ
Citation: A. Mayer et al., Radioimmunoguided surgery in colorectal cancer using a genetically engineered anti-CEA single-chain Fv antibody, CLIN CANC R, 6(5), 2000, pp. 1711-1719
Catalytic activity of an in vivo tumor targeted anti-CEA scFv :: carboxypeptidase G2 fusion protein
Authors: Bhatia, J Sharma, SK Chester, KA Pedley, RB Boden, RW Read, DA Boxer, GM Michael, NP Begent, RHJ
Citation: J. Bhatia et al., Catalytic activity of an in vivo tumor targeted anti-CEA scFv :: carboxypeptidase G2 fusion protein, INT J CANC, 85(4), 2000, pp. 571-577
A novel technique, using radioluminography, for the measurement of uniformity of radiolabelled antibody distribution in a colorectal cancer xenograftmodel
Authors: Flynn, AA Green, AJ Boxer, GM Casey, JL Pedley, RB Begent, RHJ
Citation: Aa. Flynn et al., A novel technique, using radioluminography, for the measurement of uniformity of radiolabelled antibody distribution in a colorectal cancer xenograftmodel, INT J RAD O, 43(1), 1999, pp. 183-189
Enhancement of antibody-directed enzyme prodrug therapy in colorectal xenografts by an antivascular agent
Authors: Pedley, RB Sharma, SK Boxer, GM Boden, R Stribbling, SM Davies, L Springer, CJ Begent, RHJ
Citation: Rb. Pedley et al., Enhancement of antibody-directed enzyme prodrug therapy in colorectal xenografts by an antivascular agent, CANCER RES, 59(16), 1999, pp. 3998-4003
Risultati: 1-9 |